News

Chronic HBV was associated with increased risk for adverse COVID-19 outcomes, but the risk was lower among coinfected patients vaccinated against COVID-19.
Biocon Biologics has gained approval from the US Food and Drug Administration (FDA) for the intravenous use of Jobevne ...
From a public health point of view, there are no specific strategies for prevention of hepatitis E virus infection. Exposures ...
You're not likely to hear it brought up in casual conversation, but recombinant DNA has changed the world in a relatively ...